72 related articles for article (PubMed ID: 16857343)
1. Sef-S, an alternative splice isoform of sef gene, inhibits NIH3T3 cell proliferation via a mitogen-activated protein kinases p42 and p44 (ERK1/2)-independent mechanism.
Rong Z; Ren Y; Cheng L; Li Z; Li Y; Sun Y; Li H; Xiong S; Chang Z
Cell Signal; 2007 Jan; 19(1):93-102. PubMed ID: 16857343
[TBL] [Abstract][Full Text] [Related]
2. A role for extracellular and transmembrane domains of Sef in Sef-mediated inhibition of FGF signaling.
Kovalenko D; Yang X; Chen PY; Nadeau RJ; Zubanova O; Pigeon K; Friesel R
Cell Signal; 2006 Nov; 18(11):1958-66. PubMed ID: 16603339
[TBL] [Abstract][Full Text] [Related]
3. Alternative splicing generates an isoform of the human Sef gene with altered subcellular localization and specificity.
Preger E; Ziv I; Shabtay A; Sher I; Tsang M; Dawid IB; Altuvia Y; Ron D
Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1229-34. PubMed ID: 14742870
[TBL] [Abstract][Full Text] [Related]
4. Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy.
Ishibe T; Nakayama T; Okamoto T; Aoyama T; Nishijo K; Shibata KR; Shima Y; Nagayama S; Katagiri T; Nakamura Y; Nakamura T; Toguchida J
Clin Cancer Res; 2005 Apr; 11(7):2702-12. PubMed ID: 15814652
[TBL] [Abstract][Full Text] [Related]
5. Activation of TAK1 by Sef-S induces apoptosis in 293T cells.
Sun X; Wang Y; Yang S; Ren F; Xia Y; Chang Z
Cell Signal; 2013 Oct; 25(10):2039-46. PubMed ID: 23770285
[TBL] [Abstract][Full Text] [Related]
6. Sef inhibits fibroblast growth factor signaling by inhibiting FGFR1 tyrosine phosphorylation and subsequent ERK activation.
Kovalenko D; Yang X; Nadeau RJ; Harkins LK; Friesel R
J Biol Chem; 2003 Apr; 278(16):14087-91. PubMed ID: 12604616
[TBL] [Abstract][Full Text] [Related]
7. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
8. Ligand-independent activation of fibroblast growth factor receptor-2 by carboxyl terminal alterations.
Lorenzi MV; Castagnino P; Chen Q; Chedid M; Miki T
Oncogene; 1997 Aug; 15(7):817-26. PubMed ID: 9266968
[TBL] [Abstract][Full Text] [Related]
9. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
10. hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling.
Xiong S; Zhao Q; Rong Z; Huang G; Huang Y; Chen P; Zhang S; Liu L; Chang Z
J Biol Chem; 2003 Dec; 278(50):50273-82. PubMed ID: 12958313
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
12. Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells.
Pardo OE; Arcaro A; Salerno G; Tetley TD; Valovka T; Gout I; Seckl MJ
Oncogene; 2001 Nov; 20(52):7658-67. PubMed ID: 11753643
[TBL] [Abstract][Full Text] [Related]
13. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
Chang ZL; Lin MQ; Wang MZ; Yao Z
Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
[TBL] [Abstract][Full Text] [Related]
14. Identification of Sef, a novel modulator of FGF signalling.
Tsang M; Friesel R; Kudoh T; Dawid IB
Nat Cell Biol; 2002 Feb; 4(2):165-9. PubMed ID: 11802164
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-2 is an immediate-early gene induced by mechanical stress in osteogenic cells.
Li CF; Hughes-Fulford M
J Bone Miner Res; 2006 Jun; 21(6):946-55. PubMed ID: 16753025
[TBL] [Abstract][Full Text] [Related]
16. Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.
Zhang H; Zhao X; Yan L; Li M
Gynecol Oncol; 2011 Sep; 122(3):669-74. PubMed ID: 21663947
[TBL] [Abstract][Full Text] [Related]
17. Specific inhibition of FGF-induced MAPK activation by the receptor-like protein tyrosine phosphatase LAR.
Wang X; Weng LP; Yu Q
Oncogene; 2000 May; 19(19):2346-53. PubMed ID: 10822386
[TBL] [Abstract][Full Text] [Related]
18. Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways.
Raucci A; Bellosta P; Grassi R; Basilico C; Mansukhani A
J Cell Physiol; 2008 May; 215(2):442-51. PubMed ID: 17960591
[TBL] [Abstract][Full Text] [Related]
19. Dexamethasone inhibits basic fibroblast growth factor-stimulated gastric epithelial cell proliferation.
Luo JC; Lin HY; Lu CL; Wang LY; Chang FY; Lin HC; Huang YC; Ng KM; Chi CW; Lee SD
Biochem Pharmacol; 2008 Oct; 76(7):841-9. PubMed ID: 18692028
[TBL] [Abstract][Full Text] [Related]
20. Expression of the SNT-1/FRS2 phosphotyrosine binding domain inhibits activation of MAP kinase and PI3-kinase pathways and antiestrogen resistant growth induced by FGF-1 in human breast carcinoma cells.
Manuvakhova M; Thottassery JV; Hays S; Qu Z; Rentz SS; Westbrook L; Kern FG
Oncogene; 2006 Sep; 25(44):6003-14. PubMed ID: 16682955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
